Literature DB >> 26986042

Challenges in the pharmacological treatment of geriatric asthma.

Fabio Agusta1, Salvatore Battaglia1, Alida Benfante1, Mario Spatafora1, Nicola Scichilone1,2.   

Abstract

Asthma in older populations is characterized by frequent comorbid conditions, which increase the risk of side effects and of detrimental interactions between respiratory and non-respiratory drugs. These observations lead to the need to manage asthma in older populations by applying a multidimensional assessment and a multidisciplinary treatment; therefore, we favor the use of the 'geriatric' term to define asthma in the elderly. Geriatric asthma is a complex disease, which may not necessarily imply that it is also complicated, although the two conditions may often coexist. On this basis, the switch from an organ-driven management to the holistic approach may be the key factor to attain optimal control of the disease in this age range. The current review discusses the age-related factors affecting asthma treatment in the oldest individuals, such as the comorbid conditions, and age-related changes of metabolism and excretion that can impair the efficacy and safety of drugs.

Keywords:  Aging; adherence; asthma; comorbidity; inhaled treatment

Mesh:

Substances:

Year:  2016        PMID: 26986042     DOI: 10.1586/17512433.2016.1167596

Source DB:  PubMed          Journal:  Expert Rev Clin Pharmacol        ISSN: 1751-2433            Impact factor:   5.045


  3 in total

Review 1.  Leukotriene Receptor Antagonists for the Treatment of Asthma in Elderly Patients.

Authors:  Hoang Kim Tu Trinh; Ga-Young Ban; Ji-Ho Lee; Hae-Sim Park
Journal:  Drugs Aging       Date:  2016-10       Impact factor: 3.923

Review 2.  The evidence on tiotropium bromide in asthma: from the rationale to the bedside.

Authors:  Dejan Radovanovic; Pierachille Santus; Francesco Blasi; Marco Mantero
Journal:  Multidiscip Respir Med       Date:  2017-05-04

3.  Applicability of the MASK-Air® App to Severe Asthma Treated with Biologic Molecules: A Pilot Study.

Authors:  Alida Benfante; Bernardo Sousa-Pinto; Gianluca Pillitteri; Salvatore Battaglia; Joao Fonseca; Jean Bousquet; Nicola Scichilone
Journal:  Int J Mol Sci       Date:  2022-09-29       Impact factor: 6.208

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.